<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?DTDIdentifier.IdentifierValue article.dtd?>
  <?DTDIdentifier.IdentifierType system?>
  <?SourceDTD.DTDName article.dtd?>
  <?SourceDTD.Version 1.0?>
  <?ConverterInfo.XSLTName bmc2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cardiovasc Diabetol</journal-id>
      <journal-title-group>
        <journal-title>Cardiovascular Diabetology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1475-2840</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3116465</article-id>
      <article-id pub-id-type="publisher-id">1475-2840-10-38</article-id>
      <article-id pub-id-type="pmid">21554682</article-id>
      <article-id pub-id-type="doi">10.1186/1475-2840-10-38</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Investigation</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Hypercholesterolemia and a candidate gene within the 12q24 locus</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Gragnoli</surname>
            <given-names>Claudia</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>claudia.gragnoli@gmail.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Laboratory of Molecular Genetics of Complex and Monogenic Disorders, Department of Medicine and Cellular &amp; Molecular Physiology and Biostatistics, Penn State University and M. S. Hershey Medical Center, Hershey, PA, USA</aff>
      <aff id="I2"><label>2</label>Center for Biotechnology and Department of Biology, Temple University's College of Science &amp; Technology, Philadelphia, PA, USA</aff>
      <aff id="I3"><label>3</label>Molecular Biology Laboratory, Bios Biotech Multi-Diagnostic Health Center, Rome, Italy</aff>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>10</volume>
      <fpage>38</fpage>
      <lpage>38</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>3</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>5</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2011 Gragnoli; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Gragnoli; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.cardiab.com/content/10/1/38"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>The 12q24 locus entails at least one gene responsible for hypercholesterolemia. Within the 12q24 locus lies the gene of proteasome modulator 9 (<italic>PSMD9</italic>). <italic>PSMD9 </italic>is in linkage with type 2 diabetes (T2D), T2D-nephropathy and macrovascular pathology in Italian families and <italic>PSMD9 </italic>rare mutations contribute to T2D.</p>
        </sec>
        <sec>
          <title>Aims</title>
          <p>In the present study, we aimed at determining whether the <italic>PSMD9 </italic>T2D risk single nucleotide polymorphisms (SNPs) <italic>IVS3 + nt460 A &gt; G, IVS3 + nt437 T &gt; C </italic>and <italic>E197G A &gt; G </italic>are linked to hypercholesterolemia in 200 T2D Italian families.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>We characterized 200 Italian families for presence and/or absence of hypercholesterolemia characterized by LDL levels &#x2265; 100 mg/dl in drug-na&#xEF;ve patients and/or presence of a diagnosis of hypercholesterolemia in a patient treated with statin medication. The phenotypes were described as unknown in all cases in which the diagnosis was either unclear or the data were missing. We tested in the 200 Italians families for evidence of linkage of the <italic>PSMD9 </italic>SNPs with hypercholesterolemia. The non-parametric linkage analysis was performed for the qualitative phenotype by using the Merlin software; the Lod score and correspondent P-value were calculated. For the significant linkage score, 1000 replicates were performed to calculate the empirical P-value.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The <italic>PSMD9 </italic>gene SNPs studied show linkage to hypercholesterolemia. The results are not due to random chance.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p><italic>PSMD9 </italic>should be tested in all populations reporting linkage to hypercholesterolemia within the chromosome 12q24 locus. The impact of this gene on hypercholesterolemia and contribution to cardio- and cerebrovascular events may be high.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>SNPs</kwd>
        <kwd>
          <italic>PSMD9</italic>
        </kwd>
        <kwd>Linkage</kwd>
        <kwd>Hypercholesterolemia</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>The chromosome 12q24 locus is linked to dyslipidemia and hypercholesterolemia and must entail at least one gene responsible for these phenotypes [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Dyslipidemia is an important cardiovascular risk factor for T2D. Dyslipidemia is a major modifiable risk factor of atherosclerosis, which introduces the possibility of both treatment and prevention of the cardiovascular complications of T2D [<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>Within the 12q24 locus is located the gene of proteasome modulator 9 (<italic>PSMD9</italic>). PSMD 9 is highly expressed in pancreatic islets and it is a coactivator of insulin gene transcription, and <italic>PSMD9 </italic>gene dosage abnormalities cause beta-cell dysfunction and contribute to type 2 diabetes (T2D) [<xref ref-type="bibr" rid="B4">4</xref>]. PSMD9 is a ubiquitously expressed protein. We reported that <italic>PSMD9 </italic>rarely causes T2D by unique mutations [<xref ref-type="bibr" rid="B5">5</xref>] and that the <italic>PSMD9 IVS3 + nt460 A &gt; G, IVS3 + nt437 C &gt; T </italic>and <italic>E197G A &gt; G </italic>single nucleotide polymorphisms (SNPs) are linked to late-onset T2D via the recessive model [<xref ref-type="bibr" rid="B6">6</xref>] and to MODY3 [<xref ref-type="bibr" rid="B7">7</xref>] via the additive model. We recently published that the <italic>PSMD9 IVS3 + nt460 A &gt; G, IVS3 + nt437 C &gt; T </italic>and <italic>E197G A &gt; G </italic>T2D risk SNPs are linked to T2D-nephropathy [<xref ref-type="bibr" rid="B8">8</xref>] as well as to macrovascular pathology [<xref ref-type="bibr" rid="B9">9</xref>]. Insulin is a lipid-synthetic hormone, thus alteration in a gene regulating insulin gene transcription may alter lipid metabolism as well and contribute to hypercholesterolemia. Furthermore, overexpression in transgenic mice of the coactivator Bridge-1, homologous of PSMD9, results in elevated triglyceride levels in Bridge-1/PSMD9 with severe diabetes compared to non-transgenic control mice [<xref ref-type="bibr" rid="B10">10</xref>].</p>
      <p>We aimed at identifying in the present study whether the coactivator of insulin transcription <italic>PSMD9 </italic>may contribute to linkage to hypercholesterolemia in 200 Italian T2D families. Thus, we tested the <italic>PSMD9 </italic>T2D risk SNPs for linkage to hypercholesterolemia.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Ethics Statement</title>
        <p>the subjects were all recruited following the Helsinki declaration guidelines. Subjects gave written informed consent and the Penn State College of Medicine Ethical Committee approved the study.</p>
      </sec>
      <sec>
        <title>Families</title>
        <p>We recruited 200 Italian T2D affected siblings and families. We excluded families with identical twins and we confirmed that our families were at least for three generations Italians and had no known ancestor of not-Italian origin. The Italian population lives in a peninsula and it is very suitable for genetic studies as there are no concerns for genetic admixture.</p>
      </sec>
      <sec>
        <title>Clinical Phenotyping</title>
        <p>We characterized the Italian family's subjects, including those unaffected by T2D, for LDL cholesterol &#x2265;100 mg/dl in drug-na&#xEF;ve patients and/or presence of hypercholesterolemia in patients treated with statin medication.</p>
        <p>Phenotypes are described as unknown if diagnosis is unclear or data are missing. In our 200 Italian families, hypercholesterolemia is present in 87.30% of the families.</p>
      </sec>
      <sec>
        <title>Sequencing</title>
        <p>We amplified by PCR the <italic>IVS3 PSMD9 </italic>region containing the <italic>+nt460 A &gt; G </italic>and <italic>+nt437 C &gt; T </italic>SNPs and the exon 5 coding region containing the <italic>E197G A &gt; G </italic>SNP with specific primers [<xref ref-type="bibr" rid="B5">5</xref>] in the affected and unaffected family members. We directly sequenced the PCR products, status post-purification via EXOSAP-IT on an automated ABI 3730 Sequencer.</p>
      </sec>
      <sec>
        <title>Statistical Analysis</title>
        <p>We tested in the 200 Italians families for linkage of the <italic>PSMD9 </italic>above-mentioned SNPs with hypercholesterolemia. Non-parametric linkage analysis for the qualitative phenotype was performed for the three SNPs via the latest version of Merlin software [<xref ref-type="bibr" rid="B11">11</xref>]. Merlin analyzed all the informative families (n = 84) within this dataset. The number of individuals in the 200 families is 928; the number of individuals in the 84 families is 390 (table <xref ref-type="table" rid="T1">1</xref>).</p>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p>Population Demographics</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">Population</th>
                <th align="center">T2D Families/Subjects</th>
                <th align="center">Sex (F/M)</th>
                <th align="center">Families Informative for Hypercholesterolemia/Subjects</th>
                <th align="center">Sex (F/M)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>100% Italians</bold>
                </td>
                <td align="center">200/928</td>
                <td align="center">467/461</td>
                <td align="center">84/390</td>
                <td align="center">199/191</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>F = female, M = male.</p>
          </table-wrap-foot>
        </table-wrap>
        <p>Allele frequencies were calculated from the data. The result is reported in LOD score as calculated by Merlin.</p>
        <p>To rule out the presence of a false positive in our result, we calculated how many times P-values equal or inferior to the real one were expected by chance in 1,000 replicates of simulations by using the gene dropping method: this analysis replaces real data with simulated data, while maintaining the pedigree structure, allele frequencies and recombination fraction. These datasets are generated under the null hypothesis of no linkage.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <p>The results of the non-parametric linkage analysis performed are reported in table <xref ref-type="table" rid="T2">2</xref> with the LOD score, the corresponding P-value and the empirical P-value. The tested <italic>PSMD9 </italic>SNPs are significantly linked to hypercholesterolemia in the T2D-families. The three variants tested contribute almost equally to the results, with a non significant prevalence of the intronic variants over the coding variant.</p>
      <table-wrap id="T2" position="float">
        <label>Table 2</label>
        <caption>
          <p>Non-parametric Linkage Analysis of Hypercholesterolemia of the Italian Families by Merlin software</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th align="left">Phenotype</th>
              <th align="center">Prevalence</th>
              <th align="center">Families</th>
              <th align="center">Z Score</th>
              <th align="center">Lod</th>
              <th align="center">P</th>
              <th align="center">Empirical P</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">
                <bold>Hypercholesterolemia</bold>
              </td>
              <td align="center">87.30%</td>
              <td align="center">84</td>
              <td align="center">2.12 </td>
              <td align="center">1.24</td>
              <td align="center">0.008</td>
              <td align="center">0.007</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <p>Prevalence = phenotype prevalence among the family subjects studied; Families = families number analyzed; Z score = derived from the non-parametric linkage analysis by Merlin; Lod = Lod score derived from the non-parametric linkage analysis by Merlin; P = p-value; Empirical P = p-value derived from 1000 replicates by using the gene dropping method; Hypercholesterolemia defined by the presence of LDL &#x2265; 100 mg/dl in drug-na&#xEF;ve patients or by the presence of a diagnosis of hypercholesterolemia treated with a statin medication.</p>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Our study shows that the <italic>PSMD9 </italic>SNPs studied are in linkage with hypercholesterolemia in the Italian T2D families, thus making <italic>PSMD9 </italic>a possible risk gene for hypercholesterolemia. However, these findings should be replicated in families with hypercholesterolemia of other ethnicities and in particular in all ethnical groups in which the chromosome 12q24 locus was reported as linked to elevated cholesterol [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>] to confirm the general relevance of the gene in other populations as well.</p>
      <p>The finding of our study may have an inestimable impact given the relevance of the 12q24 locus in hypercholesterolemia in several ethnical groups [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>] as well as the importance of hypercholesterolemia as a major risk factor for macrovascular disease and cerebral and cardiovascular events reducing quality of life and lifetime span [<xref ref-type="bibr" rid="B3">3</xref>]. Given the <italic>PSMD9 </italic>linkage reported with T2D-nephropathy [<xref ref-type="bibr" rid="B8">8</xref>] and with macrovascular pathology [<xref ref-type="bibr" rid="B9">9</xref>] as well, it is possible that the PSMD9 has pleiotropic effects contributing to the phenotypes associated with macrovascular pathology as well as with T2D. PSMD9 is present at high concentrations in eukaryotic cells and is part of the 26S proteasome complex, which contributes to the degradation of intracellular proteins in antigenic peptides in the immune response to antigen presentation by MHC class I cells (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org/cgi-bin/carddisp.pl?gene=PSMD9">http://www.genecards.org/cgi-bin/carddisp.pl?gene=PSMD9</ext-link>). Thus, one potential role of PSMD9 in the phenotypes associated with T2D and atherosclerosis could be related to a direct role in the pathogenesis of inflammation as an autoimmune process [<xref ref-type="bibr" rid="B12">12</xref>]. In addition, PSMD9 is mediating the magnitude and duration of the transcription of the ligand-dependent retinoid-target genes (<ext-link ext-link-type="uri" xlink:href="http://www.millipore.com/pathways/pathviewer.do?pathwayId=76">http://www.millipore.com/pathways/pathviewer.do?pathwayId=76</ext-link>). Thus, PSMD9 may, if impaired in its function due to gene variants affecting the protein sequence and/or protein dosage, alter dosage and effects of several downstream genes. In transgenic mice with pancreatic overexpression of the homologous of PSMD9, it has been shown that the increased dose of the PSMD9 protein is causing insulin deficiency and diabetes as well as hypertriglyceridemia [<xref ref-type="bibr" rid="B10">10</xref>]. In addition, an inhibition of the gene transcription in vitro also reduces insulin secretion [<xref ref-type="bibr" rid="B13">13</xref>]. Thus, the hypothesis is that given the complex network of transcription and co-activator factors that PSMD9 is associated to, both PSMD9 reduced or increased protein dose in the cell may have pathogenetic effects, by potentially contributing to phenotypes that may be either different or having an underlying contributing factor.</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>We conclude that the <italic>PSMD9 </italic>SNPs <italic>IVS3 + nt460 A &gt; G, IVS3 + nt437 C &gt; T </italic>and <italic>E197G A &gt; G </italic>are linked to the hypercholesterolemia phenotype in the Italian T2D-families tested. This finding is of relevance as hypercholesterolemia is a major contributor of cardiovascular disease in T2D, and thus the identification of genes implicated in the pathogenesis of hypercholesterolemia may lead to future primary and secondary prevention therapies implementations.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author declares that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>CG conceived and designed the study, collected the clinical information, performed the statistical analysis and drafted the manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p content-type="acknowledgment">Special thanks go to the Molecular Biology staff of Bios Biotech Multi-Diagnostic Health Center (Rome, Italy), which provided technical support for this study.</p>
      <p content-type="acknowledgment">Funding: Penn State College of Medicine</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shmulewitz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Heath</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Blundell</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Salit</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Auerbach</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Signorini</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Breslow</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Stoffel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Friedman</surname>
            <given-names>JM</given-names>
          </name>
          <article-title>Linkage analysis of quantitative traits for obesity, diabetes, hypertension, and dyslipidemia on the island of Kosrae, Federated States of Micronesia</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>3502</fpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0510156103</pub-id>
          <pub-id pub-id-type="pmid">16537441</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chasman</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Pare</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mora</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hopewell</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Peloso</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Clarke</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Cupples</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Hamsten</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kathiresan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Malarstig</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ordovas</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Ripatti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Parker</surname>
            <given-names>AN</given-names>
          </name>
          <name>
            <surname>Miletich</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Ridker</surname>
            <given-names>PM</given-names>
          </name>
          <article-title>Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis</article-title>
          <source>PLoS Genet</source>
          <year>2009</year>
          <volume>5</volume>
          <fpage>e1000730</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1000730</pub-id>
          <pub-id pub-id-type="pmid">19936222</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gotto</surname>
            <given-names>AM</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>Evolving concepts of dyslipidemia, atherosclerosis, and cardiovascular disease: the Louis F. Bishop Lecture</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2005</year>
          <volume>46</volume>
          <fpage>1219</fpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2005.06.059</pub-id>
          <pub-id pub-id-type="pmid">16198834</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Thomas</surname>
            <given-names>MKYK</given-names>
          </name>
          <name>
            <surname>Tenser</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Habener</surname>
            <given-names>JF</given-names>
          </name>
          <article-title>Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription</article-title>
          <source>Mol Cell Biol</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>8492</fpage>
          <pub-id pub-id-type="pmid">10567574</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gragnoli</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cronsell</surname>
            <given-names>J</given-names>
          </name>
          <article-title>PSMD9 gene variants within NIDDM2 may rarely contribute to type 2 diabetes</article-title>
          <source>J Cell Physiol</source>
          <year>2007</year>
          <volume>212</volume>
          <fpage>568</fpage>
          <pub-id pub-id-type="doi">10.1002/jcp.21127</pub-id>
          <pub-id pub-id-type="pmid">17516568</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gragnoli</surname>
            <given-names>C</given-names>
          </name>
          <article-title>PSMD9 gene in the NIDDM2 locus is linked to type 2 diabetes in Italians</article-title>
          <source>J Cell Physiol</source>
          <year>2010</year>
          <volume>222</volume>
          <fpage>265</fpage>
          <pub-id pub-id-type="doi">10.1002/jcp.21954</pub-id>
          <pub-id pub-id-type="pmid">19877155</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gragnoli</surname>
            <given-names>C</given-names>
          </name>
          <article-title>PSMD9 is linked to MODY3</article-title>
          <source>J Cell Physiol</source>
          <year>2010</year>
          <volume>223</volume>
          <fpage>1</fpage>
          <pub-id pub-id-type="pmid">20069546</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="other">
          <name>
            <surname>Gragnoli</surname>
            <given-names>C</given-names>
          </name>
          <article-title>T2D-nephropathy linkage within 12q24 locus</article-title>
          <source>Diabetes Res Clin Pract</source>
          <year>2011</year>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gragnoli</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Proteasome Modulator 9 and Macrovascular Pathology of T2D</article-title>
          <source>Cardiovasc Diabetol</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>32</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2840-10-32</pub-id>
          <pub-id pub-id-type="pmid">21496327</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Volinic</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Eto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>MK</given-names>
          </name>
          <article-title>Overexpression of the coactivator bridge-1 results in insulin deficiency and diabetes</article-title>
          <source>Mol Endocrinol</source>
          <year>2006</year>
          <volume>20</volume>
          <fpage>167</fpage>
          <pub-id pub-id-type="pmid">16099819</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Abecasis</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Cherny</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Cookson</surname>
            <given-names>WO</given-names>
          </name>
          <name>
            <surname>Cardon</surname>
            <given-names>LR</given-names>
          </name>
          <article-title>Merlin--rapid analysis of dense genetic maps using sparse gene flow trees</article-title>
          <source>Nat Genet</source>
          <year>2002</year>
          <volume>30</volume>
          <fpage>97</fpage>
          <pub-id pub-id-type="doi">10.1038/ng786</pub-id>
          <pub-id pub-id-type="pmid">11731797</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wick</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Millonig</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Q</given-names>
          </name>
          <article-title>The Autoimmune Pathogenesis of Atherosclerosis--An Evolutionary-Darwinian Concept</article-title>
          <source>Atherosclerosis and Autoimmunity</source>
          <year>2001</year>
          <volume>Section V</volume>
          <fpage>5</fpage>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Thomas</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Tenser</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Habener</surname>
            <given-names>JF</given-names>
          </name>
          <article-title>Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription</article-title>
          <source>Mol Cell Biol</source>
          <year>1999</year>
          <volume>19</volume>
          <fpage>8492</fpage>
          <pub-id pub-id-type="pmid">10567574</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
